Cann Group has completed its first shipment of medicinal cannabis oil to UK distribution partner Astral Health (part of the LYPHE Group), to be supplied as part of LYPHE’s participation in Project Twenty21, Europe’s largest medicinal cannabis recruitment registry.
Project Twenty21 is a patient registry providing access to medical cannabis while simultaneously gathering data on treatment efficacy. Launched in November 2019, it is the largest medicinal cannabis recruitment initiative in Europe with more than 8,000 patients enrolled through clinics and independent prescribers.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
